Please use this identifier to cite or link to this item:
https://dspace.uzhnu.edu.ua/jspui/handle/lib/51014
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sirchak, Ye. | - |
dc.contributor.author | Derbak, М. | - |
dc.contributor.author | Stan, M. | - |
dc.contributor.author | Petrichko, O. | - |
dc.contributor.author | Сірчак, Єлизавета Степанівна | uk |
dc.contributor.author | Дербак, Марія Антонівна | uk |
dc.contributor.author | Петричко, Оксана Іванівна | uk |
dc.date.accessioned | 2023-04-28T09:16:36Z | - |
dc.date.available | 2023-04-28T09:16:36Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Petrychko O. I. Influence of ursodeoxycholic acid on the cholecystokinin levels in patients with gastro-esophageal reflux disease and type 2 diabetes mellitus / Ye. Sirchak, М. Derbak, M. Stan, O. Petrichko // Georgian Med News. 2021 Mar;(312):67-71. | uk |
dc.identifier.uri | https://dspace.uzhnu.edu.ua/jspui/handle/lib/51014 | - |
dc.description.abstract | Of particular interest is the study of the peculiarities of clini-cal findings and diagnostics of gastroesophageal reflux disease (GERD) in patients with diabetes mellitus (DM). The aim of the research - to study the dynamics of cholecysto-kinin (CCK) level on the background of complex therapy using the ursodeoxycholic acid (UDCA) drug in patients with GERD with type 2 DM. 68 patients with combination of type 2 DM and GERD were examined. The levels of CCK were studied in these patients, de-pending on the clinical forms of GERD, as well as their dynam-ics on the background of UDCA therapy. More pronounced increase in the serum level of CCK in pa-tients with combination of type 2 DM and extra-esophageal manifestations of GERD was observed. Decrease in the CCK level in 2,4 – 2,7 times was reached on the background of com-plex therapy with UDCA in patients with combination of type 2 DM and GERD (p<0,01). In patients with type 2 DM and GERD, an increase in blood serum CCK level is observed, especially in case of extra-esoph-ageal form of reflux disease. The maximum concentration of CCK in blood serum was revealed in overweight patients with type 2 DM in case of an extra-esophageal form of GERD. The use of UDC medication in the complex treatment of patients with type 2 DM and GERD leads to a normalization tendency of blood serum CCK levels, as well as to a decrease in body mass in these patients. | uk |
dc.language.iso | en | uk |
dc.subject | type 2 diabetes mellitus | uk |
dc.subject | gastroesophageal reflux disease | uk |
dc.subject | cholecystokinin | uk |
dc.subject | ursodeoxycholic acid | uk |
dc.title | Influence of ursodeoxycholic acid on the cholecystokinin levels in patients with gastro-esophageal reflux disease and type 2 diabetes mellitus | uk |
dc.type | Text | uk |
dc.pubType | Стаття | uk |
Appears in Collections: | Наукові публікації кафедри анатомії людини та гістології |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
INFLUENCE OF URSODEOXYCHOLIC.pdf | 360.51 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.